Katherine U. Tavasoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katherine U. Tavasoli has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Brooke Meghan Gardner
Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
5 shared publications - Christopher D. Richardson
Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
5 shared publications - Connor J. Sheedy
University of California, Santa Barbara
4 shared publications - Jonathan T. Vu
Interdisciplinary Quantitative Biosciences Program, University of California, Santa Barbara, Santa Barbara, CA, 93106, USA
3 shared publications - Eric Z. Pang
Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
2 shared publications Julia Miyamoto
Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA
2 shared publications
Latest Publications
- Open Access
POCKET-seq enables genome-wide profiling of on- and off-target transcriptional regulation events by dCas9-KRAB during CRISPR interference experiments
CRISPR interference screens use catalytically inactive dCas9 fused to a repressor domain to enable genetic perturbations at the transcriptomic level. Interpretation of results involves identification of guide RNAs associated with the screen phenotype, followed by secondary analysis. During validation of a genetic screen, we observed different phenotypes from non-overlapping guide RNAs targeting one gene. Here, we developed POCKET-seq to map the binding of dCas9 genome-wide. We show that off-target binding occurs frequently and can generate false-positive interactions when it occurs near the promoter of genes associated with the screen phenotype. POCKET-seq classifies these false-positive and true-positive interactions using gene ontology.
Open AccessPOCKET-seq enables genome-wide profiling of on- and off-target transcriptional regulation events by dCas9-KRAB during CRISPR interference experiments
CRISPR interference screens use catalytically inactive dCas9 fused to a repressor domain to enable genetic perturbations at the transcriptomic level. Interpretation of results involves identification of guide RNAs associated with the screen phenotype, followed by secondary analysis. During validation of a genetic screen, we observed different phenotypes from non-overlapping guide RNAs targeting one gene. Here, we developed POCKET-seq to map the binding of dCas9 genome-wide. We show that off-target binding occurs frequently and can generate false-positive interactions when it occurs near the promoter of genes associated with the screen phenotype. POCKET-seq classifies these false-positive and true-positive interactions using gene ontology.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1)
Racial Variations in Retinal Oxygen Metabolic Biomarkers in Diabetic Retinopathy: A Pilot Study
Purpose: Previous studies have reported that race affects the prevalence and progression of diabetic retinopathy (DR). In this pilot study, we tested the hypothesis that there are associations between race and retinal oxygen metabolic biomarkers in subjects without diabetes or with diabetes at early stages of DR. Methods: A total of 104 subjects participated and were categorized into one of three diagnosis groups: nondiabetic (ND), diabetic without clinical DR (NDR), or diabetic with mild nonproliferative DR (mild NPDR). Subjects were also classified according to race as Asian (AS), African American (AA), Hispanic White (HW), or non‐HW (NHW). Retinal oxygen metabolic biomarkers, namely, inner retinal oxygen delivery (DO 2 ), metabolism (MO 2 ), and extraction fraction (OEF), were determined by multimodal imaging (oximetry and Doppler optical coherence tomography). Results: There were significant interactions of race and diagnosis group on retinal oxygen metabolic biomarkers. The effect of diagnosis group on MO 2 was significant in the AS group, such that MO 2 was lower in the NDR than in mild NPDR. The diagnosis group did not have a significant effect on DO 2 , OEF, or MO 2 in other races. In the ND group, there was no significant effect of race on MO 2 , while DO 2 was marginally higher in HW than NHW. OEF was higher in AS than in HW and NHW. In the NDR group, there was no significant effect of race on OEF or MO 2 , while DO 2 was higher in AA than AS, HW, and NHW. In mild NPDR, MO 2 and OEF were higher in AS than NHW, and DO 2 was not significantly affected by race. Conclusion: The preliminary findings demonstrated associations of race with retinal oxygen metabolic biomarkers, underscoring the necessity for future studies in larger cohorts with the inclusion of potential confounding factors to establish normal baselines according to race that are needed for considering racial differences for clinical evaluation of DR.
- 1 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1)
Open AccessRacial Variations in Retinal Oxygen Metabolic Biomarkers in Diabetic Retinopathy: A Pilot Study
Purpose: Previous studies have reported that race affects the prevalence and progression of diabetic retinopathy (DR). In this pilot study, we tested the hypothesis that there are associations between race and retinal oxygen metabolic biomarkers in subjects without diabetes or with diabetes at early stages of DR. Methods: A total of 104 subjects participated and were categorized into one of three diagnosis groups: nondiabetic (ND), diabetic without clinical DR (NDR), or diabetic with mild nonproliferative DR (mild NPDR). Subjects were also classified according to race as Asian (AS), African American (AA), Hispanic White (HW), or non‐HW (NHW). Retinal oxygen metabolic biomarkers, namely, inner retinal oxygen delivery (DO 2 ), metabolism (MO 2 ), and extraction fraction (OEF), were determined by multimodal imaging (oximetry and Doppler optical coherence tomography). Results: There were significant interactions of race and diagnosis group on retinal oxygen metabolic biomarkers. The effect of diagnosis group on MO 2 was significant in the AS group, such that MO 2 was lower in the NDR than in mild NPDR. The diagnosis group did not have a significant effect on DO 2 , OEF, or MO 2 in other races. In the ND group, there was no significant effect of race on MO 2 , while DO 2 was marginally higher in HW than NHW. OEF was higher in AS than in HW and NHW. In the NDR group, there was no significant effect of race on OEF or MO 2 , while DO 2 was higher in AA than AS, HW, and NHW. In mild NPDR, MO 2 and OEF were higher in AS than NHW, and DO 2 was not significantly affected by race. Conclusion: The preliminary findings demonstrated associations of race with retinal oxygen metabolic biomarkers, underscoring the necessity for future studies in larger cohorts with the inclusion of potential confounding factors to establish normal baselines according to race that are needed for considering racial differences for clinical evaluation of DR.
- Open Access
- 31 March 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108467
PEX1G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome
- 31 March 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (5) , 108467
Open AccessPEX1G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome
- Open Access
PEX1 G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome
The PEX1/PEX6 AAA-ATPase is required for the biogenesis and maintenance of peroxisomes. Mutations in HsPEX1 and HsPEX6 disrupt peroxisomal matrix protein import and are the leading cause of Peroxisome Biogenesis Disorders (PBDs). The most common disease-causing mutation in PEX1 is the Hs PEX1 G843D allele, which results in a reduction of peroxisomal protein import. Here we demonstrate that in vitro the homologous yeast mutant, Sc Pex1 G700D , reduces the stability of Pex1’s active D2 ATPase domain and impairs assembly with Pex6, but can still form an active AAA-ATPase motor. In vivo , Sc Pex1 G700D exhibits only a slight defect in peroxisome import. We generated model human Hs PEX1 G843D cell lines and show that PEX1 G843D is rapidly degraded by the proteasome, but that induced overexpression of PEX1 G843D can restore peroxisome import. Additionally, we found that the G843D mutation reduces PEX1’s affinity for PEX6, and that impaired assembly is sufficient to induce degradation of PEX1 WT . Lastly, we found that fusing a deubiquitinase to PEX1 G843D significantly hinders its degradation in mammalian cells. Altogether, our findings suggest a novel regulatory mechanism for PEX1/PEX6 hexamer assembly and highlight the potential of protein stabilization as a therapeutic strategy for PBDs arising from the G843D mutation and other PEX1 hypomorphs.
Open AccessPEX1 G843D remains functional in peroxisome biogenesis but is rapidly degraded by the proteasome
The PEX1/PEX6 AAA-ATPase is required for the biogenesis and maintenance of peroxisomes. Mutations in HsPEX1 and HsPEX6 disrupt peroxisomal matrix protein import and are the leading cause of Peroxisome Biogenesis Disorders (PBDs). The most common disease-causing mutation in PEX1 is the Hs PEX1 G843D allele, which results in a reduction of peroxisomal protein import. Here we demonstrate that in vitro the homologous yeast mutant, Sc Pex1 G700D , reduces the stability of Pex1’s active D2 ATPase domain and impairs assembly with Pex6, but can still form an active AAA-ATPase motor. In vivo , Sc Pex1 G700D exhibits only a slight defect in peroxisome import. We generated model human Hs PEX1 G843D cell lines and show that PEX1 G843D is rapidly degraded by the proteasome, but that induced overexpression of PEX1 G843D can restore peroxisome import. Additionally, we found that the G843D mutation reduces PEX1’s affinity for PEX6, and that impaired assembly is sufficient to induce degradation of PEX1 WT . Lastly, we found that fusing a deubiquitinase to PEX1 G843D significantly hinders its degradation in mammalian cells. Altogether, our findings suggest a novel regulatory mechanism for PEX1/PEX6 hexamer assembly and highlight the potential of protein stabilization as a therapeutic strategy for PBDs arising from the G843D mutation and other PEX1 hypomorphs.
- Open Access
- 5 July 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (10)
A genome-wide screen links peroxisome regulation with Wnt signaling through RNF146 and TNKS/2
Peroxisomes are membrane-bound organelles harboring metabolic enzymes. In humans, peroxisomes are required for normal development, yet the genes regulating peroxisome function remain unclear. We performed a genome-wide CRISPRi screen to identify novel factors involved in peroxisomal homeostasis. We found that inhibition of RNF146, an E3 ligase activated by poly(ADP-ribose), reduced the import of proteins into peroxisomes. RNF146-mediated loss of peroxisome import depended on the stabilization and activity of the poly(ADP-ribose) polymerases TNKS and TNKS2, which bind the peroxisomal membrane protein PEX14. We propose that RNF146 and TNKS/2 regulate peroxisome import efficiency by PARsylation of proteins at the peroxisome membrane. Interestingly, we found that the loss of peroxisomes increased TNKS/2 and RNF146-dependent degradation of non-peroxisomal substrates, including the β-catenin destruction complex component AXIN1, which was sufficient to alter the amplitude of β-catenin transcription. Together, these observations not only suggest previously undescribed roles for RNF146 in peroxisomal regulation but also a novel role in bridging peroxisome function with Wnt/β-catenin signaling during development.
- 5 July 2024
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 223 (10)
Open AccessA genome-wide screen links peroxisome regulation with Wnt signaling through RNF146 and TNKS/2
Peroxisomes are membrane-bound organelles harboring metabolic enzymes. In humans, peroxisomes are required for normal development, yet the genes regulating peroxisome function remain unclear. We performed a genome-wide CRISPRi screen to identify novel factors involved in peroxisomal homeostasis. We found that inhibition of RNF146, an E3 ligase activated by poly(ADP-ribose), reduced the import of proteins into peroxisomes. RNF146-mediated loss of peroxisome import depended on the stabilization and activity of the poly(ADP-ribose) polymerases TNKS and TNKS2, which bind the peroxisomal membrane protein PEX14. We propose that RNF146 and TNKS/2 regulate peroxisome import efficiency by PARsylation of proteins at the peroxisome membrane. Interestingly, we found that the loss of peroxisomes increased TNKS/2 and RNF146-dependent degradation of non-peroxisomal substrates, including the β-catenin destruction complex component AXIN1, which was sufficient to alter the amplitude of β-catenin transcription. Together, these observations not only suggest previously undescribed roles for RNF146 in peroxisomal regulation but also a novel role in bridging peroxisome function with Wnt/β-catenin signaling during development.
- Open Access
A genome-wide screen links peroxisome regulation with Wnt signaling through RNF146 and tankyrase
Peroxisomes are membrane-bound organelles harboring metabolic enzymes. In humans, peroxisomes are required for normal development, yet the genes regulating peroxisome function remain unclear. We performed a genome-wide CRISPRi screen to identify novel factors involved in peroxisomal homeostasis. We found that inhibition of RNF146, an E3 ligase activated by poly(ADP-ribose), reduced the import of proteins into peroxisomes. RNF146-mediated loss of peroxisome import depended on the stabilization and activity of the poly(ADP-ribose) polymerase tankyrase, which binds the peroxisomal membrane protein PEX14. We propose that RNF146 and tankyrase regulate peroxisome import efficiency by PARsylation of proteins at the peroxisome membrane. Interestingly, we found that the loss of peroxisomes increased tankyrase and RNF146-dependent degradation of non-peroxisomal substrates, including the beta-catenin destruction complex component AXIN1, which was sufficient to alter the amplitude of beta-catenin transcription. Together, these observations not only suggest previously undescribed roles for RNF146 in peroxisomal regulation, but also a novel role in bridging peroxisome function with Wnt/beta-catenin signaling during development.
Open AccessA genome-wide screen links peroxisome regulation with Wnt signaling through RNF146 and tankyrase
Peroxisomes are membrane-bound organelles harboring metabolic enzymes. In humans, peroxisomes are required for normal development, yet the genes regulating peroxisome function remain unclear. We performed a genome-wide CRISPRi screen to identify novel factors involved in peroxisomal homeostasis. We found that inhibition of RNF146, an E3 ligase activated by poly(ADP-ribose), reduced the import of proteins into peroxisomes. RNF146-mediated loss of peroxisome import depended on the stabilization and activity of the poly(ADP-ribose) polymerase tankyrase, which binds the peroxisomal membrane protein PEX14. We propose that RNF146 and tankyrase regulate peroxisome import efficiency by PARsylation of proteins at the peroxisome membrane. Interestingly, we found that the loss of peroxisomes increased tankyrase and RNF146-dependent degradation of non-peroxisomal substrates, including the beta-catenin destruction complex component AXIN1, which was sufficient to alter the amplitude of beta-catenin transcription. Together, these observations not only suggest previously undescribed roles for RNF146 in peroxisomal regulation, but also a novel role in bridging peroxisome function with Wnt/beta-catenin signaling during development.